Iuliia A Merkuleva
9PUBLICATIONS
34CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 26, 2025
Monoclonal Antibodies in Light of Mpox Outbreak: Current Research, Therapeutic Targets, and Animal Models.Vladimir N Nikitin, Iuliia A Merkuleva, Dmitriy N Shcherbakov
|May 25, 2024
Natural Antibodies Produced in Vaccinated Patients and COVID-19 Convalescents Hydrolyze Recombinant RBD and Nucleocapsid (N) Proteins.Anna M Timofeeva, Liliya Sh Shayakhmetova, Artem O Nikitin
|Dec 22, 2023
Pre-Pandemic Cross-Reactive Immunity against SARS-CoV-2 among Siberian Populations.Olga N Shaprova, Daniil V Shanshin, Evgeniia A Kolosova
|Jul 12, 2023
[Intranasal vaccine against COVID-19 based on a recombinant variant of the Sendai virus (Paramyxoviridae: Respirovirus) strain Moscow].G A Kudrov, S S Zainutdinov, A A Grazhdantseva
|Apr 28, 2023
SARS-CoV-2 RBD Conjugated to Polyglucin, Spermidine, and dsRNA Elicits a Strong Immune Response in Mice.Ekaterina A Volosnikova, Iuliia A Merkuleva, Tatiana I Esina
|Jul 27, 2022
Antibodies to the Spike Protein Receptor-Binding Domain of SARS-CoV-2 at 4-13 Months after COVID-19.Evgeniia A Kolosova, Olga N Shaprova, Daniil V Shanshin
Pageof 2
Frequent Collaborators
9 joint publications
Dmitry N Shcherbakov
4 joint publications
Svetlana V Belenkaya
3 joint publications
Mariya B Borgoyakova
3 joint publications
Daniil V Shanshin
3 joint publications
Larisa I Karpenko
2 joint publications
Valentina S Nesmeyanova
2 joint publications
Evgeniia A Kolosova
1 joint publications
S S Zainutdinov
1 joint publications
Georgy A Nevinsky
1 joint publications
G F Sivolobova
